AI medical image analysis and trust; Alzheimer's drug trial and gratitude

While some AI models can discern disease in images, their logic can't always be explained in ways that inspire trust in clinicians. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

STAT+: As AI grows in medical image analysis, concern about building trust with doctors grows too By Jayne Williamson-Lee Courtesy Nature Machine Intelligence A 'pointing game' between AI and radiologists highlighted a need to improve both how well algorithms work and explanations for how they work. Read More 'Front of the line': For Alzheimer's patients in successful trial, a feeling of gratitude By Andrew Joseph Adobe Even if lecanumab can slow progression of Alzheimer's by only a little, patients say it could mean a lot for them. Read More STAT+: How one pharma insider sees the drug pricing reform law: the impact will 'vary by product and by company' By Ed Silverman Charlie Neibergall/AP "At the end of the day, it’s a competitive market and you’ll still price as you would have," says former Gilead executive Jim Meyers. Read More Sponsored Insight by STAT Events The 2022 STAT Summit: Frazier, Fauci, Bourla, and more! On November 15 and 16, come for silo-breaking and solution-focused conversations with speakers from across the industry. They'll discuss the future of companies like Pfizer and Vertex, explore the future of digital health, and ask how we'll survive the journey to Mars.  Learn More. U.S. surgeon general says workplaces are taking a toll on Americans' mental and physical health By Elizabeth Cooney Adobe Your job can be hazardous to your health, according to a new report from the U.S. Surgeon General that highlights how the Covid-19 pandemic has revealed fractures in working Americans' mental health and well-being.  Read More Tobacco companies shower Black Democrats with campaign cash By Nicholas Florko Tobacco companies generally don't donate to many Democratic candidates for political office, but now they're prioritizing Black Democrats. Read More STAT+: Novartis agrees to license a best-selling cancer drug to dozens of low- and middle-income countries By Ed Silverman FABRICE COFFRINI/AFP/Getty Images The deal with the Medicines Patent Pool marks the first time that a voluntary licensing deal has been arranged for a cancer medication. Read More Opinion: How states can act to limit drug price increases, saving employers and workers billions By Sean Dickson Adobe Beyond the Medicare penalty, federal or state action could make it more costly for drugmakers to raise prices above the inflation rate. Read More Thursday, October 20, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser